Skip to main content

GE HealthCare Technologies Inc.

corporate_fare Company Profile

GE HealthCare Technologies Inc.

GEHC·NASDAQ·Life Sciences·CIK 0001932393

GE HealthCare Technologies Inc. is a global healthcare solutions provider offering advanced medical technology, pharmaceutical diagnostics, and AI, cloud, and software solutions. The company generates revenue from the sale of medical devices, consumable products, service capabilities, and AI-enabled cloud and software solutions. With approximately 54,000 colleagues, GE HealthCare serves customers in over 160 countries, supported by a global team of approximately 9,700 sales professionals and 8,900 field service engineers. Its customers include hospitals, health systems, and researchers, encompassing public, private, academic, and government institutions. GE HealthCare Technologies Inc. is a Delaware corporation headquartered in Chicago, Illinois. On January 3, 2023, General Electric Company completed the spin-off of GE HealthCare. The company's business is organized into four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment includes five product lines and associated service capabilities: Molecular Imaging (MI), Computed Tomography (CT), Magnetic Resonance (MR), Women's Health, and X-ray.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is a publicly traded company in the Life Sciences sector. Wiseek monitors GEHC SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • GE HealthCare Gains FDA Clearance for AI-Powered Radiation Therapy Planning System
  • GE HealthCare Partners with NordicNeuroLab to Boost Global Neuroimaging Offerings
  • GE HealthCare Slashes Annual Profit Outlook on Inflation, Q1 Earnings Miss
  • GE HealthCare Reports Q1 Earnings Miss, Net Income Down 31%, Finalizes $2.3B Intelerad Acquisition Amidst Legal & Tariff Headwinds
  • GE HealthCare Reports Mixed Q1 Results, Lowers Full-Year Profit & Free Cash Flow Guidance, Closes Intelerad Acquisition

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$20.63B
Net Income
$2.08B
Diluted EPS
$4.55
Gross Profit
$8.25B
Operating Income
$2.76B
Cash & Equivalents
$4.49B
Total Debt
$10B
Debt / Equity
0.96×
Net Margin
10.1%
Shares Outstanding
456M sh
Source: 10-K · filed 2026-02-04 · accession 0001932393-26-000007
Browse all tickers starting with G →
$66.12 +0.94% today
52-week range · as of 2026-04-29 $66.95 – $89.77
Market cap
$29.65B
Volume
3.2M (0.6× avg)
3-mo avg 5.3M
Live data · 2026-06-14 03:54 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed GEHC - Latest Insights

GEHC
Jun 04, 2026, 8:00 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $62.15
Real-time Price: $66.12 info
Change: +$3.97 (+6%) info
Market Cap: $29.65B info
GEHC
May 27, 2026, 11:22 AM EDT
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $64.37
Real-time Price: $66.12 info
Change: +$1.75 (+3%) info
Market Cap: $29.65B info
GEHC
Apr 29, 2026, 8:06 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $61.54
Real-time Price: $66.12 info
Change: +$4.58 (+7%) info
Market Cap: $29.65B info
GEHC
Apr 29, 2026, 6:26 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $64.95
Real-time Price: $66.12 info
Change: +$1.17 (+2%) info
Market Cap: $29.65B info
GEHC
Apr 29, 2026, 6:25 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $64.95
Real-time Price: $66.12 info
Change: +$1.17 (+2%) info
Market Cap: $29.65B info
GEHC
Apr 29, 2026, 6:20 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $68.65
Real-time Price: $66.12 info
Change: -$2.53 (-4%) info
Market Cap: $29.65B info
GEHC
Apr 21, 2026, 10:17 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $74.37
Real-time Price: $66.12 info
Change: -$8.25 (-11%) info
Market Cap: $29.65B info
GEHC
Apr 16, 2026, 4:55 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $73.20
Real-time Price: $66.12 info
Change: -$7.08 (-10%) info
Market Cap: $29.65B info
GEHC
Mar 17, 2026, 9:14 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $71.55
Real-time Price: $66.12 info
Change: -$5.43 (-8%) info
Market Cap: $29.65B info
GEHC
Feb 04, 2026, 6:28 AM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $80.79
Real-time Price: $66.12 info
Change: -$14.67 (-18%) info
Market Cap: $29.65B info
GEHC
Feb 04, 2026, 6:25 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $80.79
Real-time Price: $66.12 info
Change: -$14.67 (-18%) info
Market Cap: $29.65B info